Velan Capital, L.P., Ten Percent Owner Other at PROGENICS PHARMACEUTICALS INC (PGNX), bought 1,042,076 shares at $4.51 ($4.6M) on 2019-09-04, disclosed to the SEC on 2019-09-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.39 | 277,424 | $1.2M | 26.3% |
| 2 | $4.39 | 277,424 | $1.2M | 26.3% |
| 3 | $4.51 | 243,614 | $1.1M | 23.7% |
| 4 | $4.51 | 243,614 | $1.1M | 23.7% |
| Total | $4.45 avg | 1,042,076 | $4.6M | 100% |